The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2011-12-01
|
| Seria: | Oncology Reviews |
| Hasła przedmiotowe: | |
| Dostęp online: | http://oncologyreviews.org/index.php/or/article/view/157 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|